Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shasqi, Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Precision Biologics, Inc
Revolution Medicines, Inc.
Elevation Oncology
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
Genmab
Kineta Inc.
Revolution Medicines, Inc.
Imperial College London
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Astellas Pharma Inc